William Richey

Director at Tempest Therapeutics.

Earliest Form D on file: Jun 2026

2 filings at 1 company

Tempest Therapeutics

Biotech, Brisbane CA

Director

Biotech, Brisbane CA

Signed
Named
Size is amount sold, up to $30M

Filings

2

Oct 13, 2026
Option to acquire, security to be acquired, other, named · Form D
$7.5M
of $7.5M
Oct 13, 2026
Option to acquire, security to be acquired, other
Named, Director
$7.5M
$7.5M
Form D
Jun 23, 2026
Equity, option to acquire, security to be acquired, other, named · Form D
$4.1M
of $4.1M
Jun 23, 2026
Equity, option to acquire, security to be acquired, other
Named, Director
$4.1M
$4.1M
Form D

Network

At Tempest Therapeutics

11 people

Matthew Angel
Together on 2 filings
Executive Officer, Director, signed as President and Chief Executive Officer
John David Yee
Together on 2 filings
Director
Constance Ames
Together on 1 filing
Executive Officer
John Frederick
Together on 1 filing
Director
Justin Trojanowski
Together on 1 filing
Executive Officer
Nancy Freda-Smith
Together on 1 filing
Director

5 more at Tempest Therapeutics